Towards Healthcare
Syphilis Testing Market to Drive USD 4.57 Bn by 2034

Syphilis Testing Market Boosted by FDA Approvals 2025

Based on market forecasts, the global syphilis testing market, projected at USD 2.29 billion in 2024, is expected to reach USD 4.57 billion by 2034, growing at a CAGR of 6.85% over the forecast period. The market is expanding due to the global increase in syphilis cases and other sexually transmitted infections. Growth is further fueled by rising awareness, government screening initiatives, and the adoption of advanced, rapid, and accurate diagnostic technologies.

Content

  • Insight Code: 6145
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The syphilis testing market stands at USD 2.45 billion in 2025 and is expected to reach USD 4.57 billion by 2034, growing at a CAGR of 6.85% from 2024 to 2034.

North America is currently leading the syphilis testing market due to favorable regulatory support, easy access to point-of-care and at-home testing solutions, and robust reimbursement policies.

Some key players include Roche Diagnostics, Abbott Laboratories, BD (Becton, Dickinson & Co.), Siemens Healthineers, bioMérieux, and Hologic.

Key trends include the growth due to the global increase in syphills cased and other sexually transmitted infections.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions